Deletion of CCR2 but not CCR5 or CXCR3 inhibits aortic aneurysm formation

Surgery

Volumn 142, Issue 2, 2007, Pages 284-288

  MacTaggart, Jason Neal ^a   Xiong, Wanfen ^a   Knispel, Rebecca ^a   Baxter, Bernard T ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHLORIDE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; ELASTIN; EOSIN; GELATINASE A; GELATINASE B; HEMATOXYLIN;

ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE DELETION; HEART PROTECTION; HISTOLOGY; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RANK SUM TEST; ZYMOGRAPHY;

ANIMALS; AORTIC ANEURYSM, ABDOMINAL; FEMALE; GENE DELETION; LEUKOCYTES; MALE; MICE; MICE, INBRED STRAINS; MICE, MUTANT STRAINS; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE;

EID: 34547668921     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2007.04.017     Document Type: Article

References (21)

1. Rentschler M., and Baxter B.T. Pharmacological approaches to prevent abdominal aortic aneurysm enlargement and rupture. Ann N Y Acad Sci 1085 (2006) 39-46
2. Thompson R.W., Geraghty P.J., and Lee J.K. Abdominal aortic aneurysms: basic mechanisms and clinical implications. Curr Probl Surg 39 (2002) 110-230
3. Hance K.A., Tataria M., Ziporin S.J., Lee J.K., and Thompson R.W. Monocyte chemotactic activity in human abdominal aortic aneurysms: role of elastin degradation peptides and the 67-kD cell surface elastin receptor. J Vasc Surg 35 (2002) 254-261
4. Charo I.F., and Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354 (2006) 610-621
5. Colonnello J.S., Hance K.A., Shames M.L., Wyble C.W., Ziporin S.J., Leidenfrost J.E., et al. Transient exposure to elastase induces mouse aortic wall smooth muscle cell production of MCP-1 and RANTES during development of experimental aortic aneurysm. J Vasc Surg 38 (2003) 138-146
6. Schecter A.D., Calderon T.M., Berman A.B., McManus C.M., Fallon J.T., Rossikhina M., et al. Human vascular smooth muscle cells possess functional CCR5. J Biol Chem 275 (2000) 5466-5471
7. Longo G.M., Xiong W., Greiner T.C., Zhao Y., Fiotti N., and Baxter B.T. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 110 (2002) 625-632
8. Xiong W., Zhao Y., Prall A., Greiner T.C., and Baxter B.T. Key roles of CD4+ T cells and IFN-gamma in the development of abdominal aortic aneurysms in a murine model. J Immunol 172 (2004) 2607-2612
9. Yoshimura K., Aoki H., Ikeda Y., Fujii K., Akiyama N., Furutani A., et al. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat Med 11 (2005) 1330-1338
10. Pyo R., Lee J.K., Shipley J.M., Curci J.A., Mao D., Ziporin S.J., et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 105 (2000) 1641-1649
11. Daugherty A., Manning M.W., and Cassis L.A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 105 (2000) 1605-1612
12. Bobryshev Y.V., and Lord R.S. Vascular-associated lymphoid tissue (VALT) involvement in aortic aneurysm. Atherosclerosis 154 (2001) 15-21
13. Ocana E., Bohorquez J.C., Perez-Requena J., Brieva J.A., and Rodriguez C. Characterisation of T and B lymphocytes infiltrating abdominal aortic aneurysms. Atherosclerosis 170 (2003) 39-48
14. Dobrin P.B., Baumgartner N., Anidjar S., Chejfec G., and Mrkvicka R. Inflammatory aspects of experimental aneurysms. Effect of methylprednisolone and cyclosporine. Ann N Y Acad Sci 800 (1996) 74-88
15. Haringman J.J., Ludikhuize J., and Tak P.P. Chemokines in joint disease: the key to inflammation?. Ann Rheum Dis 63 (2004) 1186-1194
16. Koch A.E., Kunkel S.L., Pearce W.H., Shah M.R., Parikh D., Evanoff H.L., et al. Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms. Am J Pathol 142 (1993) 1423-1431
17. Boring L., Gosling J., Cleary M., and Charo I.F. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394 (1998) 894-897
18. Ishibashi M., Egashira K., Zhao Q., Hiasha K., Ohtani K., Ihara Y., et al. Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol 24 (2004) e174-e178
19. Zhao L., Moos M.P., Grabner R., Pedrono F., Fan J., Kaiser B., et al. The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nat Med 10 (2004) 966-973
20. Ghilardi G., Biondi M.L., Battaglioli L., Zambon A., Guagnellini E., and Scorza R. Genetic risk factor characterizes abdominal aortic aneurysm from arterial occlusive disease in human beings: CCR5 Delta 32 deletion. J Vasc Surg 40 (2004) 995-1000
21. Juvonen J., Surcel H.M., Satta J., Teppo A.M., Bloigu A., Syrjala H., et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 17 (1997) 2843-2847